全文获取类型
收费全文 | 133431篇 |
免费 | 7655篇 |
国内免费 | 1139篇 |
专业分类
耳鼻咽喉 | 2073篇 |
儿科学 | 2009篇 |
妇产科学 | 1950篇 |
基础医学 | 21253篇 |
口腔科学 | 3179篇 |
临床医学 | 12515篇 |
内科学 | 23776篇 |
皮肤病学 | 4208篇 |
神经病学 | 10678篇 |
特种医学 | 7617篇 |
外科学 | 17547篇 |
综合类 | 573篇 |
现状与发展 | 3篇 |
一般理论 | 28篇 |
预防医学 | 7067篇 |
眼科学 | 3395篇 |
药学 | 12068篇 |
中国医学 | 1539篇 |
肿瘤学 | 10747篇 |
出版年
2023年 | 938篇 |
2022年 | 2858篇 |
2021年 | 4627篇 |
2020年 | 2250篇 |
2019年 | 3141篇 |
2018年 | 3895篇 |
2017年 | 3177篇 |
2016年 | 4140篇 |
2015年 | 5752篇 |
2014年 | 6791篇 |
2013年 | 7981篇 |
2012年 | 11834篇 |
2011年 | 11348篇 |
2010年 | 6554篇 |
2009年 | 5605篇 |
2008年 | 7932篇 |
2007年 | 7545篇 |
2006年 | 6780篇 |
2005年 | 6312篇 |
2004年 | 5454篇 |
2003年 | 4744篇 |
2002年 | 4072篇 |
2001年 | 3102篇 |
2000年 | 2859篇 |
1999年 | 2186篇 |
1998年 | 934篇 |
1997年 | 694篇 |
1996年 | 528篇 |
1995年 | 467篇 |
1994年 | 411篇 |
1993年 | 343篇 |
1992年 | 770篇 |
1991年 | 718篇 |
1990年 | 662篇 |
1989年 | 580篇 |
1988年 | 482篇 |
1987年 | 478篇 |
1986年 | 348篇 |
1985年 | 386篇 |
1984年 | 267篇 |
1983年 | 197篇 |
1982年 | 135篇 |
1981年 | 174篇 |
1980年 | 131篇 |
1979年 | 229篇 |
1978年 | 165篇 |
1976年 | 135篇 |
1975年 | 126篇 |
1974年 | 144篇 |
1973年 | 123篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
31.
32.
33.
34.
35.
36.
Diseases like rotavirus afflict both upper- and lower-income countries, but most serious illnesses and deaths occur among the latter. It is a vital public health issue that vaccines for these types of global diseases can recover research and development (R&D) costs from high-priced markets quickly so that manufacturers can offer affordable prices to lower-income nations. Cost recovery depends on how high R&D costs are, and this study attempts to replace high, unverified estimates with lower, more verifiable estimates for two new vaccines, RotaTeq (Merck) and Rotarix (GlaxoSmithKline or GSK), based on detailed searches of public information and follow-up interviews with senior informants. We also offer a new perspective on “cost of capital” as a claim for recovery from public bodies. Our estimates suggest that companies can recover all fixed costs quickly from affluent markets and thus can offer these vaccines to lower-income countries at prices they can afford. Better vaccines are a shared project between companies and public health agencies; greater transparency and consistency in reporting of R&D costs is needed so that fair prices can be established. 相似文献
37.
38.
Sung Hee Chung Olof Heimbürger Bengt Lindholm Hi Bahl Lee 《Nephrology, dialysis, transplantation》2005,20(6):1207-1213
BACKGROUND: Dialysis patient mortality remains high, and this high mortality may be due to many factors. In peritoneal dialysis (PD) patients, old age, co-morbid diseases, malnutrition, low residual renal function (RRF) and a high peritoneal transport rate have been shown to influence survival, but the relative importance of these factors may differ between different patient populations. Besides, centre practice patterns may differ between centres and may influence patient survival. In addition, the literature suggests that dialysis patient survival may be better in Asian than in Caucasian patients. METHODS: The influence of centre and patient characteristics on patient survival was investigated in 132 Korean and 106 Swedish incident PD patients, who underwent initial biochemical measurements and assessment of adequacy of dialysis, nutritional status, RRF and peritoneal transport characteristics. RESULTS: At the start of PD, Korean patients had a higher prevalence of diabetes, peritoneal Kt/V(urea), peritoneal creatinine clearance and peritoneal fluid removal, and lower body mass index, RRF and dialysate to plasma creatinine concentration ratio (D/P Cr) compared with Swedish patients. Significantly more patients from Korea were placed on temporary haemodialysis before PD (100 out of 132) when compared with Swedish patients (21 out of 106). During the follow-up, there was a significantly higher rate of transfer to other units in Korea and a significantly higher rate of kidney transplantation in Sweden. On Kaplan-Meier analysis, overall patient survival did not differ and relative risk for death was also not different between the two centres even after adjustment for age, diabetes, cardiovascular disease, RRF and D/P Cr. On Cox proportional hazards multivariate analysis, age, diabetes, RRF and D/P Cr were found to be independent predictors of mortality in the combined cohort of patients. While age, diabetes and D/P Cr were independent predictors of mortality in Korean patients, age and RRF independently predicted mortality in Swedish patients. CONCLUSION: Although there were significant differences in centre and patient characteristics, we were unable to confirm a survival advantage for Korean over Swedish PD patients. The results of this study suggest that the reported difference in survival between Asian and Caucasian dialysis patients may have been due, in part, to differences in centre and patient characteristics rather than to race as such. The genetic influence on patient characteristics remains, however, to be elucidated. 相似文献
39.
40.